you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Sep 27, 09:28
731.50 -5.20 (-0.71%)
Volume
AVERAGE VOLUME
5-Day
5,508
10-Day
6,709
30-Day
6,785
536
  • Prev. Close

    736.70

  • Open Price

    735.60

  • Bid Price (Qty.)

    732.50 (1)

  • Offer Price (Qty.)

    734.80 (8)

NSE Live

Sep 27, 09:28
734.40 -2.65 (-0.36%)
Volume
AVERAGE VOLUME
5-Day
57,017
10-Day
81,266
30-Day
70,814
4,249
  • Prev. Close

    737.05

  • Open Price

    736.00

  • Bid Price (Qty.)

    733.60 (1)

  • Offer Price (Qty.)

    734.40 (7)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of Eris Lifesciences (in Rs. Cr.) Mar 21 Mar 20 Mar 19 Mar 18 Mar 17  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 1,192.64 1,058.18 967.20 827.10 729.83  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 7.51 28.97  
Revenue From Operations [Net] 1,192.64 1,058.18 967.20 819.60 700.87  
Total Operating Revenues 1,211.86 1,074.06 982.16 848.10 720.53  
Other Income 8.71 15.40 31.69 26.41 25.11  
Total Revenue 1,220.57 1,089.46 1,013.86 874.50 745.64  
EXPENSES  
Cost Of Materials Consumed 99.43 76.88 58.19 47.08 50.46  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Employee Benefit Expenses 229.30 205.69 190.66 157.32 131.22  
Finance Costs 1.80 2.16 22.90 10.55 1.03  
Depreciation And Amortisation Expenses 42.99 50.26 36.35 25.64 22.76  
Other Expenses 313.72 328.46 292.89 234.70 215.61  
Total Expenses 826.07 758.11 696.50 562.27 475.26  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 394.50 331.35 317.36 312.23 270.39  
Exceptional Items 0.00 0.00 0.00 0.00 0.00  
Profit/Loss Before Tax 394.50 331.35 317.36 312.23 270.39  
Tax Expenses-Continued Operations  
Current Tax 69.40 60.70 71.07 68.79 57.04  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -30.04 -25.85 -44.86 -51.54 -33.26  
Other Direct Taxes 0.00 0.00 0.00 0.00 0.00  
Total Tax Expenses 39.36 34.84 26.21 17.25 23.78  
Profit/Loss After Tax And Before ExtraOrdinary Items 355.14 296.51 291.15 294.98 246.61  
Profit/Loss From Continuing Operations 355.14 296.51 291.15 294.98 246.61  
Profit/Loss For The Period 355.14 296.51 291.15 294.98 246.61  
Minority Interest 0.00 -0.01 -0.35 -0.87 0.18  
Consolidated Profit/Loss After MI And Associates 355.14 296.50 290.80 294.11 246.79  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 26.00 22.00 21.00 21.00 18.00  
Diluted EPS (Rs.) 26.00 22.00 21.00 21.00 18.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 74.68 38.97 0.00 0.00 0.00  
Tax On Dividend 0.00 8.01 0.00 0.00 0.00  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

No News.
No News.
No News.
No News.